Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Block
Tamara Isakova

Showing results (111-120 of 198) with videos related to

Pageof 20
Sort By:
Magnetic Resonance in Medicine|September 19, 2017
Validation of highly accelerated real-time cardiac cine MRI with radial k-space sampling and compressed sensing in patients at 1.5T and 3THassan Haji-Valizadeh, Amir A Rahsepar, Jeremy D Collins, et al.
Kidney International|April 29, 2026
Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophyDominik Kentrup, Jane Joy Thomas, Guillaume Courbon, et al.
Seminars in Dialysis|October 3, 2002
How should hyperphosphatemia be managed in dialysis patients?Geoffrey Block, Jaime Uribarri, Joseph A Coladonato, et al.
Kidney International|August 2, 2021
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney diseaseRupal C Mehta, Monique E Cho, Xuan Cai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2018
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 DiabetesClaire Gerber, Xuan Cai, Jungwha Lee, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.
Clinical Pharmacology in Drug Development|January 25, 2019
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and SafetyEdward Lee, John P Gibbs, Maurice G Emery, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2009
Klotho variants and chronic hemodialysis mortalityDavid J Friedman, Maryam Afkarian, Hector Tamez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 22, 2015
Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older IndividualsTamara Isakova, Xuan Cai, Jungwha Lee, et al.
Bone Research|May 3, 2019
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney diseaseCorey Dussold, Claire Gerber, Samantha White, et al.
Pageof 20

Showing results (111-120 of 198) with videos related to

Sort By:
Pageof 20
Magnetic Resonance in Medicine|September 19, 2017
Validation of highly accelerated real-time cardiac cine MRI with radial k-space sampling and compressed sensing in patients at 1.5T and 3THassan Haji-Valizadeh, Amir A Rahsepar, Jeremy D Collins, et al.
Kidney International|April 29, 2026
Estrogen protects female mice with chronic kidney disease from fibroblast growth factor 23-induced left ventricular hypertrophyDominik Kentrup, Jane Joy Thomas, Guillaume Courbon, et al.
Seminars in Dialysis|October 3, 2002
How should hyperphosphatemia be managed in dialysis patients?Geoffrey Block, Jaime Uribarri, Joseph A Coladonato, et al.
Kidney International|August 2, 2021
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney diseaseRupal C Mehta, Monique E Cho, Xuan Cai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2018
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 DiabetesClaire Gerber, Xuan Cai, Jungwha Lee, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 15, 2017
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseMichel Chonchol, Berenice Gitomer, Tamara Isakova, et al.
Clinical Pharmacology in Drug Development|January 25, 2019
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and SafetyEdward Lee, John P Gibbs, Maurice G Emery, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2009
Klotho variants and chronic hemodialysis mortalityDavid J Friedman, Maryam Afkarian, Hector Tamez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 22, 2015
Associations of FGF23 With Change in Bone Mineral Density and Fracture Risk in Older IndividualsTamara Isakova, Xuan Cai, Jungwha Lee, et al.
Bone Research|May 3, 2019
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney diseaseCorey Dussold, Claire Gerber, Samantha White, et al.
Pageof 20